NESTABS DHA
NESTABS DHA Prenatal Multi-vitamin/Mineral Tablet
Approved
Approval ID
2dd25bf2-f1a7-4bc4-bdf2-12d9065ea0cf
Product Type
HUMAN PRESCRIPTION DRUG LABEL
Effective Date
Jan 18, 2023
Manufacturers
FDA
WOMENS CHOICE PHARMACEUTICALS LLC
DUNS: 833067841
Products 1
Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.
Sodium Ascorbate, Cholecalciferol, di-alpha-Tocopheryl Acetate, Thiamine Mononitrate, Riboflavin, Niacinamide, Pyridoxine HCL, Folic Acid, Cyanocobalamin, Calcium Formate, Calcium Carbonate, Ferrous (II) bis-Glycinate Chelate, Potassium Iodide, Zinc Oxide, Choline Bitartrate, with doconexent and icosapent
Product Details
FDA regulatory identification and product classification information
FDA Identifiers
NDC Product Code50967-317
Product Classification
G
Generic Name
Sodium Ascorbate, Cholecalciferol, di-alpha-Tocopheryl Acetate, Thiamine Mononitrate, Riboflavin, Niacinamide, Pyridoxine HCL, Folic Acid, Cyanocobalamin, Calcium Formate, Calcium Carbonate, Ferrous (II) bis-Glycinate Chelate, Potassium Iodide, Zinc Oxide, Choline Bitartrate, with doconexent and icosapent
Product Specifications
Effective DateJanuary 18, 2023
FDA Product Classification